Product Information
ROPINIROLE HCL 4 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0804 per EA under NDC 43547027350. Its NADAC has been published 196 times since Sep 28, 2022.
Strength
4 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547027350
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078110On Market Since
9/20/2011
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 4 MG TABLET has been published 196 times since Sep 28, 2022, and over the history we have for it it has risen 5.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0804 per EA |
|---|---|
| All-time high | $0.0975 (Nov 16, 2022) |
| All-time low | $0.0681 (Nov 20, 2024) |
| 52-week high | $0.0852 |
| 52-week low | $0.0771 |
| Median price | $0.0816 |
| Average price | $0.0818 |
| Largest weekly change | +33.7% (Jan 18, 2023) |
| Weeks tracked | 196 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 4 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0804 per EA (NDC 43547027350), effective Jun 24, 2026.
How has the price of ROPINIROLE HCL 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 4 MG TABLET has risen 5.8%. It has been tracked across 196 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 4 MG TABLET?
Since Sep 28, 2022, the NADAC for ROPINIROLE HCL 4 MG TABLET has ranged from a low of $0.0681 (Nov 20, 2024) to a high of $0.0975 (Nov 16, 2022), with a median of $0.0816 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 4 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ROPINIROLE HCL 4 MG TABLET, but none are currently priced below it.
Who manufactures ROPINIROLE HCL 4 MG TABLET?
ROPINIROLE HCL 4 MG TABLET (NDC 43547027350) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification